Canadian institutes team up to develop new imaging agents

05/4/2009 | HealthImaging.com

MDS Nordion, the University of British Columbia and TRIUMF -- Canada's facility for particle and nuclear physics -- have reached a three-year agreement to develop new diagnostic imaging agents using a class of medical isotopes called radiometals and chelates, which are substances that bind to and protect radiometals when inside the body. The partnership aims to use the agents in the detection and treatment of cancer and heart disease.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD